Published in Gastroenterology on December 01, 1999
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev (2002) 2.29
Fertility and pregnancy in the patient with inflammatory bowel disease. Gut (2006) 1.77
Recent developments in gastroenterology. BMJ (2002) 1.59
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers. Br J Cancer (2004) 1.43
Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease. Gut (2002) 1.17
Emerging treatments for complex perianal fistula in Crohn's disease. World J Gastroenterol (2009) 1.15
Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut (2008) 1.12
New life in a sleeper: thalidomide and Crohn's disease. Gastroenterology (1999) 1.10
Thalidomide for treatment of severe intestinal bleeding. Gut (2004) 1.09
Hereditary auto-inflammatory disorders and biologics. Springer Semin Immunopathol (2006) 1.06
Small therapeutic molecules for the treatment of inflammatory bowel disease. Gut (2002) 1.00
Thalidomide for Crohn's disease. Gastroenterology (2000) 0.98
Successful treatment of refractory esophageal Crohn's disease with infliximab. Dig Dis Sci (2001) 0.89
Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway. Am J Cancer Res (2014) 0.88
Thalidomide and its derivatives: emerging from the wilderness. Postgrad Med J (2003) 0.86
Thalidomide induces mucosal healing in Crohn's disease: case report. World J Gastroenterol (2011) 0.86
Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production. World J Gastroenterol (2007) 0.86
Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat - role of endothelial cell-leukocyte interaction. Br J Pharmacol (2001) 0.84
Treatment of pediatric refractory Crohn's disease with thalidomide. World J Gastroenterol (2011) 0.81
Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease. Expert Opin Drug Saf (2012) 0.79
TNFα causes thrombin-dependent vagal neuron apoptosis in inflammatory bowel disease. J Gastrointest Surg (2014) 0.77
Potent inhibition of cytokine production from intestinal lamina propria T cells by phosphodiesterase-4 inhibitory thalidomide analogues. J Clin Immunol (2001) 0.77
Effect of cyclosporine in a murine model of experimental colitis. Dig Dis Sci (2002) 0.77
Infliximab treatment for Crohn's disease. Postgrad Med J (2001) 0.77
Newer Therapies for Inflammatory Bowel Disease. Curr Treat Options Gastroenterol (2004) 0.77
Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis. World J Gastroenterol (2011) 0.76
Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats. PLoS One (2016) 0.76
Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease. Exp Mol Med (2017) 0.75
Intractable insomnia after cessation of treatment with thalidomide. Gastroenterology (2001) 0.75
Effective treatment of gastrointestinal bleeding with thalidomide - Chances and limitations. World J Gastroenterol (2016) 0.75
Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study. Therap Adv Gastroenterol (2017) 0.75
Thalidomide for inflammatory bowel disease: Systematic review. Medicine (Baltimore) (2016) 0.75
Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol (2017) 0.75
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Inequality in income and mortality in the United States: analysis of mortality and potential pathways. BMJ (1996) 13.16
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02
Income inequality and mortality in metropolitan areas of the United States. Am J Public Health (1998) 5.54
Light scattering and birefringence changes during nerve activity. Nature (1968) 4.65
Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23
Optical measurement of membrane potential. Rev Physiol Biochem Pharmacol (1978) 4.22
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
Changes in axon fluorescence during activity: molecular probes of membrane potential. J Membr Biol (1974) 3.80
Mortality among the elderly in the Alameda County Study: behavioral and demographic risk factors. Am J Public Health (1987) 3.80
Analysis of the potential-dependent changes in optical retardation in the squid giant axon. J Physiol (1971) 3.50
Changes in absorption, fluorescence, dichroism, and Birefringence in stained giant axons: : optical measurement of membrane potential. J Membr Biol (1977) 3.49
Representation of odorants by receptor neuron input to the mouse olfactory bulb. Neuron (2001) 3.48
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med (2000) 2.78
Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor study. Int J Epidemiol (1996) 2.73
Frequent attendance at religious services and mortality over 28 years. Am J Public Health (1997) 2.73
Acquisition of word-object associations by 14-month-old infants. Dev Psychol (1998) 2.66
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology (1989) 2.66
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Religious attendance increases survival by improving and maintaining good health behaviors, mental health, and social relationships. Ann Behav Med (2001) 2.59
Visual stimuli induce waves of electrical activity in turtle cortex. Proc Natl Acad Sci U S A (1997) 2.56
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis (1999) 2.55
Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med (1996) 2.49
Rapid changes in intracellular free calcium concentration. Detection by metallochromic indicator dyes in squid giant axon. Biophys J (1975) 2.44
Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol (1991) 2.42
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol (2001) 2.39
A large change in axon fluorescence that provides a promising method for measuring membrane potential. Nat New Biol (1973) 2.37
Improvements in optical methods for measuring rapid changes in membrane potential. J Membr Biol (1981) 2.34
Optical recording of impulses in individual neurones of an invertebrate central nervous system. Nature (1974) 2.30
Changes in neuron structure during action potential propagation and synaptic transmission. Physiol Rev (1973) 2.25
Natural history of leisure-time physical activity and its correlates: associations with mortality from all causes and cardiovascular disease over 28 years. Am J Epidemiol (1996) 2.24
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Social connections and mortality from all causes and from cardiovascular disease: prospective evidence from eastern Finland. Am J Epidemiol (1988) 2.20
Optical recording of neuronal activity in an invertebrate central nervous system: simultaneous monitoring of several neurons. J Neurophysiol (1977) 2.16
The superior mesenteric artery syndrome. The disease that isn't, or is it? J Clin Gastroenterol (1985) 2.13
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease. Aliment Pharmacol Ther (2013) 2.12
Bowel function of long-term tube-fed patients consuming formulae with and without dietary fiber. JPEN J Parenter Enteral Nutr (1990) 2.06
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc (1980) 2.04
Optical mapping of electrical activity in rat somatosensory and visual cortex. J Neurosci (1985) 2.04
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. Gastroenterology (1993) 2.03
Sarcomatoid (spindle cell) carcinoma of the head and neck mucosal region: a clinicopathologic review of 103 cases from a tertiary referral cancer centre. Head Neck Pathol (2010) 2.02
Vitamin-D status in long-stay geriatric patients. Lancet (1975) 1.98
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther (2005) 1.96
Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol (1999) 1.90
Changes in axon birefringence during the action potential. J Physiol (1970) 1.85
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Three fluorescent protein voltage sensors exhibit low plasma membrane expression in mammalian cells. J Neurosci Methods (2006) 1.82
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther (2005) 1.79
Ten years of experience with isolated urachal anomalies in children. J Urol (1997) 1.75
Gluconeogenesis, glucose handling, and structural changes in livers of the adult offspring of rats partially deprived of protein during pregnancy and lactation. J Clin Invest (1997) 1.74
Simultaneous optical monitoring of activity of many neurons in invertebrate ganglia using a 124-element photodiode array. J Neurophysiol (1981) 1.73
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology (1998) 1.71
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol (1993) 1.70
Successful aging: predictors and associated activities. Am J Epidemiol (1996) 1.65
Light scattering and birefringence changes during activity in the electric organ of electrophorus electricus. J Physiol (1969) 1.63
Inhibition by pactamycin of the initiation of protein synthesis. Binding of N-acetylphenylalanyl transfer ribonucleic acid and polyuridylic acid to ribosomes. Biochemistry (1969) 1.62
Alcohol consumption and mortality in Alameda County. J Chronic Dis (1987) 1.59
Imaging membrane potential with voltage-sensitive dyes. Biol Bull (2000) 1.59
A naphthyl analog of the aminostyryl pyridinium class of potentiometric membrane dyes shows consistent sensitivity in a variety of tissue, cell, and model membrane preparations. J Membr Biol (1992) 1.59
Genetically encoded fluorescent sensors of membrane potential. Brain Cell Biol (2008) 1.57
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
Optical methods for monitoring neuron activity. Annu Rev Neurosci (1978) 1.56
Predictors of disability retirement. Scand J Work Environ Health (1997) 1.52
Optical monitoring of activity from many areas of the in vitro and in vivo salamander olfactory bulb: a new method for studying functional organization in the vertebrate central nervous system. J Neurosci (1983) 1.52
Attention-getting and attention-holding processes of infant visual preferences. Child Dev (1972) 1.50
Changes in light scattering associated with the action potential in crab nerves. J Physiol (1971) 1.47
Changes in light scattering that accompany the action potential in squid giant axons: potential-dependent components. J Physiol (1972) 1.46
Frequent hangovers and cardiovascular mortality in middle-aged men. Epidemiology (1997) 1.45
Socioeconomic status and carotid atherosclerosis. Circulation (1995) 1.45
Intracellular pH: measurement, control, and metabolic interrelationships. CRC Crit Rev Clin Lab Sci (1975) 1.43
An increasing prevalence of hearing impairment and associated risk factors over three decades of the Alameda County Study. Am J Public Health (1997) 1.42
Evidence for structural changes during the action potential in nerves from the walking legs of Maia squinado. J Physiol (1968) 1.42
The dynamics of disability and functional change in an elderly cohort: results from the Alameda County Study. J Am Geriatr Soc (1992) 1.41
Charge-shift probes of membrane potential. Characterization of aminostyrylpyridinium dyes on the squid giant axon. Biophys J (1985) 1.41
The effect of simulated metabolic acidosis on intracellular pH and lactate metabolism in the isolated perfused rat liver. Clin Sci Mol Med (1973) 1.40
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity. Gastroenterology (2000) 1.40
Idiopathic infantile hypercalcaemia--a continuing enigma. Arch Dis Child (1984) 1.39
Presynaptic inhibition of primary olfactory afferents mediated by different mechanisms in lobster and turtle. J Neurosci (1999) 1.38
Lactic acidosis revisited. Diabetes (1983) 1.36
The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol (1998) 1.35
Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci (1989) 1.34
Acid-base and metabolic disturbances in fulminant hepatic failure. Gut (1975) 1.34
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut (1997) 1.32
A large change in dye absorption during the action potential. Biophys J (1974) 1.32
Developmental change in infants' perception of correlations among attributes. Child Dev (1986) 1.32
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol (2000) 1.31
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther (2004) 1.31
Sex differentials in morbidity and mortality risks examined by age and cause in the same cohort. Am J Epidemiol (1989) 1.30
Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Epidemiology (1994) 1.28
Head and neck synovial sarcomas. J Surg Oncol (1993) 1.26